Bioorganic and Medicinal Chemistry Letters p. 923 - 928 (2008)
Update date:2022-08-03
Topics:
Gauthier, Jacques Yves
Chauret, Nathalie
Cromlish, Wanda
Desmarais, Sylvie
Duong, Le T.
Falgueyret, Jean-Pierre
Kimmel, Donald B.
Lamontagne, Sonia
Leger, Serge
LeRiche, Tammy
Li, Chun Sing
Masse, Frederic
McKay, Daniel J.
Nicoll-Griffith, Deborah A.
Oballa, Renata M.
Palmer, James T.
Percival, M. David
Riendeau, Denis
Robichaud, Joel
Rodan, Gideon A.
Rodan, Sevgi B.
Seto, Carmai
Therien, Michel
Truong, Vouy-Linh
Venuti, Michael C.
Wesolowski, Gregg
Young, Robert N.
Zamboni, Robert
Black, W. Cameron
Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724. Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclinical species. Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib. Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.
View MoreChongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Jiangxi Huashi Pharmaceutical Co., Ltd
Contact:+86-795-4509628
Address:Ningbo Ave., Fengtian Industrial Park, Fengxin Country, Jiangxi, China.
Contact:+86 18616952870
Address:Area
Shenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Zhejiang Kangfeng Chemical Co.,LTD.
Contact:+86-579-86709687
Address:Xueshizhai Industrial Zone, Weishan Town,Dongyang City, Zhejiang Province ,China
Doi:10.1039/c4ra04845h
(2014)Doi:10.1021/om0497137
(2004)Doi:10.1021/ic50216a007
(1981)Doi:10.1021/jm00160a050
(1986)Doi:10.1016/j.jorganchem.2004.05.022
(2004)Doi:10.1021/ic901371g
(2009)